M. Katz, Failing the Acid Test, Archives of Internal Medicine, vol.170, issue.9, pp.747-748, 2010.
DOI : 10.1001/archinternmed.2010.64

I. Forgacs and A. Loganayagam, Overprescribing proton pump inhibitors, BMJ, vol.336, issue.7634, pp.2-3, 2008.
DOI : 10.1136/bmj.39406.449456.BE

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174763

P. Haastrup, M. Paulsen, J. Zwisler, L. Begtrup, J. Hansen et al., Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: A nationwide observational study, European Journal of General Practice, vol.12, issue.4, 2014.
DOI : 10.3109/13814788.2014.905535

J. Milton, I. Hill-smith, and S. Jackson, Prescribing for older people, BMJ, vol.336, issue.7644, pp.606-609, 2008.
DOI : 10.1136/bmj.39503.424653.80

L. Roulet, N. Vernaz, E. Giostra, Y. Gasche, and J. Desmeules, Effets indésirables des inhibiteurs de la pompe à proton : faut-il craindre de les prescrire au long cours ? Rev Médecine Interne, août, vol.33, issue.8, pp.439-445, 2012.

T. Vallot and N. Mathieu, Action des inhibiteurs de la pompe ?? protons sur la s??cr??tion gastrique acide??: m??canismes, effets des traitements au long cours, EMC - Gastro-ent??rologie, vol.2, issue.4, pp.1-6, 2007.
DOI : 10.1016/S1155-1968(07)27476-0

P. López, N. , V. Villán, Y. , G. Menéndez et al., Potentially inappropriate prescribing in patients over 65 years-old in a primary care health centre. Atencion Primaria Soc Espanola Med Fam Comunitaria, 2014.

I. Marie, A. Moutot, A. Tharrasse, M. Hellot, S. Robaday et al., Ad??quation aux??recommandations des??prescriptions des??inhibiteurs de??la??pompe ????protons dans??un??service de??m??decine interne, La Revue de M??decine Interne, vol.28, issue.2, pp.86-93, 2007.
DOI : 10.1016/j.revmed.2006.09.030

G. Masclee, M. Sturkenboom, and E. Kuipers, A Benefit???Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly, Drugs & Aging, vol.69, issue.5, pp.263-282, 2014.
DOI : 10.1007/s40266-014-0166-4

R. Wedemeyer and H. Blume, Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update, Drug Safety, vol.24, issue.5, pp.201-211, 2014.
DOI : 10.1007/s40264-014-0144-0

C. Howden and P. Kahrilas, Editorial: Just How ???Difficult??? Is It to Withdraw PPI Treatment?, The American Journal of Gastroenterology, vol.25, issue.7, pp.1538-1540, 2010.
DOI : 10.1053/j.gastro.2008.08.045

A. Hungin, G. Rubin, O. Flanagan, and H. , Factors influencing compliance in long-term proton pump inhibitor therapy in general practice, Br J Gen Pract J R Coll Gen Pract. juin, vol.49, issue.443, pp.463-464, 1999.

M. Buon, C. Gaillard, J. Martin, S. Fedrizzi, B. Mosquet et al., Risk of Proton Pump Inhibitor-Induced Mild Hyponatremia in Older Adults, Journal of the American Geriatrics Society, vol.26, issue.11, pp.2052-2054, 2013.
DOI : 10.1111/jgs.12534

I. Fenoglio, C. Guy, M. Beyens, G. Mounier, F. Marsille et al., Hyponatr??mies d???origine m??dicamenteuse. ?? propos d???une s??rie de 54 cas notifi??s au Centre R??gional de Pharmacovigilance de Saint-??tienne, Th??rapie, vol.66, issue.2, pp.139-148, 2011.
DOI : 10.2515/therapie/2011011

C. Luk, R. Parsons, Y. Lee, and J. Hughes, Proton Pump Inhibitor???Associated Hypomagnesemia: What Do FDA Data Tell Us?, Annals of Pharmacotherapy, vol.28, issue.6, pp.773-780, 2013.
DOI : 10.1136/bmj.d5087

R. Laheij, M. Sturkenboom, R. Hassing, J. Dieleman, B. Stricker et al., Risk of Community-Acquired Pneumonia and Use of Gastric Acid???Suppressive Drugs, JAMA, vol.292, issue.16, pp.1955-1960, 2004.
DOI : 10.1001/jama.292.16.1955

S. Herzig, M. Howell, L. Ngo, and E. Marcantonio, Acid-Suppressive Medication Use and the Risk for Hospital-Acquired Pneumonia, JAMA, vol.301, issue.20, pp.2120-2128, 2009.
DOI : 10.1001/jama.2009.722

C. Eom, C. Jeon, J. Lim, E. Cho, S. Park et al., Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis, Canadian Medical Association Journal, vol.183, issue.3, pp.310-319, 2011.
DOI : 10.1503/cmaj.092129

Y. Yang, J. Lewis, S. Epstein, and D. Metz, Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture, JAMA, vol.296, issue.24, pp.2947-2953, 2006.
DOI : 10.1001/jama.296.24.2947

J. Geller and J. Adams, Proton Pump Inhibitor Therapy and Hip Fracture Risk, JAMA, vol.297, issue.13, pp.1429-1430, 2007.
DOI : 10.1001/jama.297.13.1429-a

H. Khalili, E. Huang, B. Jacobson, C. Camargo, . Jr et al., Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study, BMJ, vol.344, issue.jan30 5, p.372, 2012.
DOI : 10.1136/bmj.e372

S. Dial, J. Delaney, A. Barkun, and S. Suissa, Use of Gastric Acid???Suppressive Agents and the Risk of Community-Acquired <EMPH TYPE="ITAL">Clostridium difficile</EMPH>???Associated Disease, JAMA, vol.294, issue.23, pp.2989-2995, 2005.
DOI : 10.1001/jama.294.23.2989

C. Kwok, A. Arthur, C. Anibueze, S. Singh, R. Cavallazzi et al., Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis, The American Journal of Gastroenterology, vol.63, issue.7, pp.1011-1019, 2012.
DOI : 10.1186/1471-2334-11-194

D. Elzen, W. Groeneveld, Y. De-ruijter, W. Souverijn, J. Le-cessie et al., Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals, Alimentary Pharmacology & Therapeutics, vol.46, issue.Suppl. 1, pp.491-497, 2008.
DOI : 10.1111/j.1365-2036.2008.03601.x

E. Andrès, E. Noureddine-henoun-loukili, G. Noel, . Kaltenbach, A. E. Maher-ben-abdelgheni et al., Jean-Louis Schlienger, and Jean-Frédéric Blicklé. Vitamin B12 (cobalamin) deficiency in elderly patients, CMAJ, pp.251-259, 1713.

M. Delgado, S. Calleja, L. Suarez, and J. Pascual, Recurrent confusional episodes associated with hypomagnesaemia due to esomeprazol, Case Reports, vol.2013, issue.aug05 1, 2013.
DOI : 10.1136/bcr-2013-200501

S. Chen, X. Song, X. Gao, M. Li, Z. Chen et al., Proton Pump Inhibitors and the Risk of Colorectal Cancer, Journal of Clinical Gastroenterology, vol.45, issue.2, p.177, 2011.
DOI : 10.1097/MCG.0b013e3181ea181e

Y. Yang, S. Hennessy, K. Propert, W. Hwang, A. Sedarat et al., Chronic Proton Pump Inhibitor Therapy and the Risk of Colorectal Cancer, Gastroenterology, vol.133, issue.3, pp.748-754, 2007.
DOI : 10.1053/j.gastro.2007.06.022

A. Desilets, N. Asal, and K. Dunican, Considerations for the Use of Proton-Pump Inhibitors in Older Adults, The Consultant Pharmacist, vol.27, issue.2, pp.114-120, 2012.
DOI : 10.4140/TCP.n.2012.114

R. Scagliarini, E. Magnani, A. Praticò, R. Bocchini, P. Sambo et al., Inadequate Use of Acid-Suppressive Therapy in Hospitalized Patients and Its Implications for General Practice, Digestive Diseases and Sciences, vol.46, issue.12, pp.2307-2311, 2005.
DOI : 10.1007/s10620-005-3052-4

M. Andro, S. Estivin, and A. Gentric, Prescriptions m??dicamenteuses en g??riatrie??: overuse (sur-utilisation), misuse (mauvaise utilisation), underuse (sous-utilisation). Analyse qualitative ?? partir des ordonnances de 200??patients entrant dans un service de court s??jour g??riatrique, La Revue de M??decine Interne, vol.33, issue.3, pp.122-127, 2012.
DOI : 10.1016/j.revmed.2011.11.016

J. Barletta and D. Sclar, Use of Proton Pump Inhibitors for the Provision of Stress Ulcer Prophylaxis: Clinical and Economic Consequences, PharmacoEconomics, vol.2, issue.5, pp.5-13, 2014.
DOI : 10.1007/s40273-013-0119-5

M. Mazer-amirshahi, P. Mullins, J. Van-den-anker, A. Meltzer, and J. Pines, Rising rates of proton pump inhibitor prescribing in US ED, Am J Emerg Med. 21 mars, 2014.

J. Ferreiro, M. Ueno, D. Capodanno, B. Desai, K. Dharmashankar et al., Pharmacodynamic Effects of Concomitant Versus Staggered Clopidogrel and Omeprazole Intake: Results of a Prospective Randomized Crossover Study, Circulation: Cardiovascular Interventions, vol.3, issue.5, pp.436-441, 2010.
DOI : 10.1161/CIRCINTERVENTIONS.110.957829

K. Brendel, G. Weigel, A. Griesmacher, O. Pachinger, and J. Mair, Low prevalence of clopidogrel and acetylsalicylic acid resistance in patients with acute myocardial infarction and pantoprazole treatment in everyday practice, International Journal of Cardiology, vol.168, issue.1, pp.589-590, 2013.
DOI : 10.1016/j.ijcard.2013.01.246

B. Spiegel, M. Farid, M. Van-oijen, L. Laine, C. Howden et al., Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers, Alimentary Pharmacology & Therapeutics, vol.141, issue.Suppl. 2, pp.871-881, 2009.
DOI : 10.1111/j.1365-2036.2009.03935.x

D. Bhatt, B. Cryer, C. Contant, M. Cohen, A. Lanas et al., CP; COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease, N Engl J Med, 2010.

P. Ho, T. Maddox, L. Wang, S. Fihn, R. Jesse et al., Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome, JAMA, vol.301, issue.9
DOI : 10.1001/jama.2009.261

P. Hsu, K. Lai, and C. Liu, Esomeprazole With Clopidogrel Reduces Peptic Ulcer Recurrence, Compared With Clopidogrel Alone, in Patients With Atherosclerosis, Gastroenterology, vol.140, issue.3, pp.791-798, 2011.
DOI : 10.1053/j.gastro.2010.11.056

M. Jones, S. Greenfield, S. Jowett, C. Bradley, and R. Seal, Proton pump inhibitors: a study of GPs' prescribing, Family Practice, vol.18, issue.3, pp.333-338, 2001.
DOI : 10.1093/fampra/18.3.333

R. Fuzier, J. Maguès, E. Dupuis, S. Pomiès, S. Segui et al., Inhibiteurs de la pompe ?? protons??: impact d???une ??valuation des pratiques professionnelles sur la pertinence des prescriptions, Annales Fran??aises d'Anesth??sie et de R??animation, vol.30, issue.11, pp.814-818, 2011.
DOI : 10.1016/j.annfar.2011.07.004

R. Ramaswamy, V. Maio, J. Diamond, A. Talati, C. Hartmann et al., Potentially inappropriate prescribing in elderly: assessing doctor knowledge, confidence and barriers, Journal of Evaluation in Clinical Practice, vol.41, issue.3, 1011111365.
DOI : 10.1111/j.1365-2753.2010.01494.x

J. Bashford, J. Norwood, and S. Chapman, Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database, BMJ, vol.317, issue.7156, pp.452-456, 1998.
DOI : 10.1136/bmj.317.7156.452

K. Mccoll and D. Gillen, Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to Treat, Gastroenterology, vol.137, issue.1, pp.20-22, 2009.
DOI : 10.1053/j.gastro.2009.05.015

M. Littner, F. Leung, E. Ballard, B. Huang, and N. Samra, Effects of 24 Weeks of Lansoprazole Therapy on Asthma Symptoms, Exacerbations, Quality of Life, and Pulmonary Function in Adult Asthmatic Patients With Acid Reflux Symptoms, Chest, vol.128, issue.3, pp.1128-1135, 2005.
DOI : 10.1378/chest.128.3.1128

J. Mastronarde, N. Anthonisen, M. Castro, J. Holbrook, and F. Leone, Efficacy of esomeprazole for treatment of poorly controlled asthma, N Engl J Med. 9 avr, vol.360, issue.15, pp.1487-1499, 2009.

M. Wermeling, W. Himmel, G. Behrens, and D. Ahrens, Why do GPs continue inappropriate hospital prescriptions of proton pump inhibitors? A qualitative study, European Journal of General Practice, vol.170, issue.3, 2013.
DOI : 10.1046/j.1365-2710.2000.00312.x

J. Heidelbaugh, D. Metz, and Y. Yang, Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?, International Journal of Clinical Practice, vol.341, issue.Suppl. 6, pp.582-591, 2012.
DOI : 10.1111/j.1742-1241.2012.02921.x

P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, O. Mahony et al., STOPP (Screening Tool of Older Person??s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation, Int. Journal of Clinical Pharmacology and Therapeutics, vol.46, issue.02, pp.72-83, 2008.
DOI : 10.5414/CPP46072

P. Lang, Y. Hasso, J. Belmin, I. Payot, J. Baeyens et al., Adaptation en langue française d'un outil de détection de la prescription médicamenteuse inappropriée chez la personne âgée, Can J Public Health, vol.100, issue.6, pp.426-457, 2009.

A. Travis, D. Pievsky, and J. Saltzman, Endoscopy in the Elderly, 1495?1501; quiz 1494, p.1502, 2012.
DOI : 10.1016/j.dld.2007.08.004